Pharmaceutical Ethics Depend on Market Demand
Pharmaceutical Ethics Depend on Market Demand Imagine, for a moment, a world where stress, insomnia, anxiety, and exhaustion suddenly became unprofitable. No billion-dollar antidepressant blockbusters. No sleep-aid empire. No chronic-condition revenue streams that pad quarterly earnings like memory foam. What would happen? Overnight, the same companies that marketed pills as "life-saving" would pivot faster than a startup chasing VC funding. Wellness gurus would replace psychiatrists. Meditation apps would replace prescriptions. And "science" would release a flurry of studies proving that breathing exercises are actually more effective than SSRIs—curiously, just as the patent on those SSRIs was about to expire. Funny, isn't it? How "science" often arrives holding a sponsorship contract. --- The Diagnosis That Pays the Bills Let's state the uncomfortable truth plainly: Pharmaceutical ethics are not dictated by patient welfare. They are dictated by m...